The study highlights the large and rising cost of the disease: an estimated $132 billion, or approximately $92 billion in direct healthcare expenditures and $40 billion in lost productivity attributed to missed workdays, disability, and early mortality. After adjusting for differences in...

The rising trends both in drug addiction and crime rates are of major public concern in Germany. Surprisingly, the economic theory of crime seems to ignore the drugs-crime nexus, whereas the criminological literature considers illicit drug use a main reason of criminal activities. This paper...

At present, a first round of hospital benchmarking as required by German law on health care reform takes place. After extensive discussions between hospitals and insurance companies, which are jointly responsible to deliver benchmarking results, a method with some peculiar characteristics was...

This research develops an evolutionary growth theory that captures the intricate time path of life expectancy in the process of development, shedding new light on the origin of the remarkable rise in life expectancy since the Agricultural Revolution. The theory argues that social, economic and...

Although a number of studies have been conducted on health production functions, little attention has been given to pharmaceuticals as a separate input into the production of health. Building upon existing published work, this paper uses an alternative specification and more recent data to...

A three period overlapping generations model is developed to investigate the impact of shorter life expectancy due to disease, on human capital investment decisions and income growth. This research is particularly relevant to Sub-Saharan Africa given the dramatic reduction in life expectancy due...